CSF2 and diabetes mellitus: Later, Machen et al. reported that tolDCs prepared in GM-CSF + IL-4 and by antisense oligonucleotides against DC’s surface costimulatory molecules reduced diabetes incidence in NOD mice, but not if they were coadministered with a lysate from the NIT-1 β cell line (8).